Elizabeth Wendel, MD
Urology · Columbus, GANPI 1932594249
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (55.4%), food and beverage and other — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 69.3% of it on its own, with 35 other manufacturers making up the rest. Reporting peaked in 2021 at $7,172 and has fallen 89.4% since, to $763 in 2025. Among urology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 221 payments — averaging $98.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$15K
- Boston Scientific$3K
- AbbVie$691
- Endo Pharmaceuticals Inc.$385
- Astellas Pharma US Inc$369
- Axonics, Inc.$280
- plus $2K from 30 others
What the payments were for
- Travel & lodging$1,6348%
- Food & beverage$5,04023%
- Education$12,00455%
- Other$3,00014%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 7 | $15,027 |
| Boston Scientific | 36 | $3,033 |
| AbbVie(2 entities) | 37 | $691 |
| Endo Pharmaceuticals Inc. | 21 | $385 |
| Astellas Pharma US Inc | 18 | $369 |
| Axonics, Inc. | 14 | $280 |
| Procept Biorobotics Corporation | 6 | $253 |
| Endo USA, Inc. | 10 | $198 |
| Teleflex LLC | 4 | $177 |
| Myriad Genetic Laboratories, Inc. | 7 | $123 |
| Sumitomo Pharma America, Inc. | 7 | $117 |
| Rochester Medical Corporation | 5 | $101 |
| Urovant Sciences Inc | 5 | $96 |
| ABC Home Medical Supply, Inc. | 4 | $89 |
| Medtronic | 5 | $82 |
| Angiodynamics, Inc. | 1 | $66 |
| Pfizer | 3 | $59 |
| Laborie Medical Technologies Corp. | 3 | $55 |
| Cook Medical LLC | 2 | $46 |
| Blue Earth Diagnostics | 2 | $45 |
| Merck | 2 | $45 |
| Ambu Inc. | 3 | $39 |
| Dentsply IH Inc. | 2 | $33 |
| Coloplast | 2 | $31 |
| AstraZeneca | 2 | $29 |
| Antares Pharma, Inc. | 2 | $29 |
| Johnson & Johnson | 1 | $26 |
| Myovant Sciences Inc. | 1 | $22 |
| Calyxo, Inc. | 1 | $20 |
| Olympus America Inc. | 1 | $18 |
| Bioprotect Medical, Inc. | 1 | $17 |
| Dornier Medtech America, Inc | 1 | $17 |
| Profound Medical Corp. | 1 | $17 |
| Travere Therapeutics, Inc. | 2 | $16 |
| SRS Medical Systems, Inc. | 1 | $13 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$9,000
- Da Vinci Surgical System$6,000
- Solyx SIS System$1,461
- LithoVue$230
- GENERAL - THERAPIES$102
How this compares
$21,677 in reported general payments places this provider in the 90th percentile of 369 urology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 297 | $167,819 |
| GemtesaVibegron | 88 | $63,696 |
| Tamsulosin Hcl | 318 | $3,885 |
| Mirabegron ErMirabegron | 11 | $3,671 |
| Estradiol | 41 | $2,668 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 149 | $2,360 |
| Testosterone Cypionate | 26 | $1,379 |
| Finasteride | 82 | $782 |
| Trimethoprim | 22 | $759 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 21 | $672 |
| NitrofurantoinNitrofurantoin Macrocrystal | 14 | $644 |
| Ciprofloxacin Hcl | 181 | $521 |
| Tadalafil | 22 | $415 |
| Fluconazole | 30 | $325 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $171 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $369 | $167,819297 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $117 | $63,69688 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 369 urology providers in Georgia.
Other urology in Columbus
- Vahan KassabianRoswell$1.6M
- Lewis KritemanRoswell$864K
- Daniel CanterDecatur$329K
- Tariq HakkyAtlanta$140K
- Sherita KingAugusta$108K
- Brittani Barrett-HarlowFayetteville$100K
- James BennettAtlanta$93K
- Anthony BarnesAtlanta$89K
- Scott MillerRoswell$85K
- Matthew SandAtlanta$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.